Transoral microsurgery for treatment of laryngeal and pharyngeal cancers

Current Oncology Reports

Volumn 15, Issue 2, 2013, Pages 134-141

  Suárez, Carlos ^a,b   Rodrigo, Juan P ^a,b  

^a HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

^b DEPARTAMENTO DE BIOQUÍMICA Y BIOLOGÍA MOLECULAR   (Spain)

Author keywords

Glottic carcinoma; Hypopharyngeal carcinoma; Oropharyngeal carcinoma; Radiotherapy; Supraglottic carcinoma; Transoral laser microsurgery

Indexed keywords

CISPLATIN; DOCETAXEL; FLUOROURACIL;

ADJUVANT CHEMORADIOTHERAPY; ARTICLE; CANCER RADIOTHERAPY; COST EFFECTIVENESS ANALYSIS; DISEASE SPECIFIC SURVIVAL; HUMAN; HYPOPHARYNX CANCER; INTERMETHOD COMPARISON; LARYNGECTOMY; LARYNX CANCER; LASER COAGULATION; LASER SURGERY; MICROSURGERY; ORGAN PRESERVATION; OROPHARYNX CANCER; OVERALL SURVIVAL; PHARYNX CANCER; RECURRENCE FREE SURVIVAL; SURGICAL APPROACH; SURVIVAL RATE; TISSUE PRESERVATION; TRACHEOSTOMY; TRANSORAL LASER MICROSURGERY; TREATMENT OUTCOME;

HUMANS; LARYNGEAL NEOPLASMS; MICROSURGERY; NATURAL ORIFICE ENDOSCOPIC SURGERY; PHARYNGEAL NEOPLASMS;

EID: 84879607036     PISSN: 15233790     EISSN: 15346269     Source Type: Journal    
DOI: 10.1007/s11912-012-0286-0     Document Type: Article

References (68)

1. Karatzanis AD, Waldfahrer F, Psychogios G, et al. Resection margins and other prognostic factors regarding surgically treated glottic carcinomas. J Surg Oncol. 2010;101:131-6.
2. Ansarin M, Santoro L, Cattaneo A, et al. Laser surgery for early glottic cancer: impact of margin status on local control and organ preservation. Arch Otolaryngol Head Neck Surg. 2009;135:385-90.
3. Blanch JL, Vilaseca I, Bernal-Sprekelsen M, et al. Prognostic significance of surgical margins in transoral CO(2) laser microsurgery for T1-T4 pharyngo-laryngeal cancers. Eur Arch Otorhinolaryngol. 2007;264:1045-51.
4. Jackel MC, Ambrosch P, Martin A, Steiner W. Impact of re-resection for inadequate margins on the prognosis of upper aerodigestive tract cancer treated by laser microsurgery. Laryngoscope. 2007;117:350-6.
5. Michel J, Fakhry N, Duflo S, et al. Prognostic value of the status of resection margins after endoscopic laser cordectomy for T1a glottic carcinoma. Eur Ann Otorhinolaryngol Head Neck Dis. 2011;128:297-300.
6. Hartl DM, de Monès E, Hans S, et al. Treatment of early-stage glottic cancer by transoral laser resection. Ann Otol Rhinol Laryngol. 2007;116:832-6.
7. Lucioni M, Marioni G, Bertolin A, et al. Glottic laser surgery: outcomes according to 2007 ELS classification. Eur Arch Otorhinolaryngol. 2011;268:1771-8.
8. Jeong WJ, Kim H, Ahn JC, et al. Serial endoscopic analysis of the glottis following laser cordectomy: from an oncological perspective. Lasers Med Sci. 2012;27:1025-31.
9. Just T, Lankenau E, Prall F, et al. Optical coherence tomography allows for the reliable identification of laryngeal epithelial dysplasia and for precise biopsy: a clinicopathological study of 61 patients undergoing microlaryngoscopy. Laryngoscope. 2010;120:1964-70.
10. Pogorzelski B, Hanenkamp U, Goetz M, et al. Systematic intraoperative application of confocal endomicroscopy for early detection and resection of squamous cell carcinoma of the head and neck: a preliminary report. Arch Otolaryngol Head Neck Surg. 2012;138:404-11.
11. Verma SP, Dailey SH. Overcoming nasal discomfort - a novel method for office-based laser surgery. Laryngoscope. 2011;121:2396-8.
12. • Peretti G, Piazza C, Cocco D, et al. Transoral CO(2) laser treatment for T(is)-T(3) glottic cancer: the University of Brescia experience on 595 patients. Head Neck. 2010;32:977-83. This provides a clear presentation of results by T stage in an important series.
13. Vilaseca I, Bernal-Sprekelsen M, Blanch JL. Transoral laser microsurgery for T3 laryngeal tumors: Prognostic factors. Head Neck. 2010;32:929-38.
14. López-Álvarez F, Rodrigo JP, Llorente-Pendás JL, Suárez-Nieto C. Transoral laser microsurgery in advanced carcinomas of larynx and pharynx. Acta Otorrinolaringol Esp. 2011;62:95-102.
15. Blanch JL, Vilaseca I, Caballero M, et al. Outcome of transoral laser microsurgery for T2-T3 tumors growing in the laryngeal anterior commissure. Head Neck. 2011;33:1252-9.
16. Olthoff A, Ewen A, Wolff HA, et al. Organ function and quality of life after transoral laser microsurgery and adjuvant radiotherapy for locally advanced laryngeal cancer. Strahlenther Onkol. 2009;185:303-9.
17. Hinni ML, Salassa JR, Grant DG, et al. Transoral laser microsurgery for advanced laryngeal cancer. Arch Otolaryngol Head Neck Surg. 2007;133:1198-204.
18. Roedel RM, Matthias C, Wolff HA, et al. Transoral laser microsurgery for recurrence after primary radiotherapy of early glottic cancer. Auris Nasus Larynx. 2010;37:474-81.
19. Han YJ, Lee HS, Kim SW, et al. Transoral laser microsurgery of recurrent early glottic cancer after radiation therapy: clinical feasibility and limitations. Ann Otol Rhinol Laryngol. 2012;121:375-82.
20. Schrijvers ML, van Riel EL, Langendijk JA, et al. Higher laryngeal preservation rate after CO2 laser surgery compared with radiotherapy in T1a glottic laryngeal carcinoma. Head Neck. 2009;31:759-64.
21. • Higgins KM, Shah MD, Ogaick MJ, Enepekides D. Treatment of early-stage glottic cancer: meta-analysis comparison of laser excision versus radiotherapy. J Otolaryngol Head Neck Surg. 2009;38:603-12. This is as meta-analysis of oncologic and functional outcomes.
22. Feng Y, Wang B, Wen S. Laser surgery versus radiotherapy for T1-N0 glottic cancer: a meta-analysis. ORL J Otorhinolaryngol Relat Spec. 2011;73:336-42.
23. Viani L, Stell PM, Dalby JE. Recurrence after radiotherapy for glottic carcinoma. Cancer. 1991;67:577-84.
24. Eckel HE. Endoscopic laser resection of supraglottic carcinoma. Otolaryngol Head Neck Surg. 1997;117:681-7.
25. Preuss SF, Cramer K, Klussmann JP, et al. Transoral laser surgery for laryngeal cancer: outcome, complications and prognostic factors in 275 patients. Eur J Surg Oncol. 2009;35:235-40.
26. Phillips TJ, Sader C, Brown T, et al. Transoral laser microsurgery versus radiation therapy for early glottic cancer in Canada: cost analysis. J Otolaryngol Head Neck Surg. 2009;38:619-23.
27. •• Higgins KM. What treatment for early-stage glottic carcinoma among adult patients: CO2 endolaryngeal laser excision versus standard fractionated external beam radiation is superior in terms of cost utility? Laryngoscope. 2011;121:116-34. This is an extremely well conducted meta-analysis of costs and outcomes.
28. Merrot O, Bige V, Poupart M, et al. Comparison between external radiotherapy and laser microsurgery for the treatment of TisT1N0 glottic carcinoma: Clinical modelling and cost-minimization study from the French national health insurance payer's point of view. Rev Laryngol Otol Rhinol (Bord). 2010;131:257-62.
29. Sjögren EV, van Rossum MA, Langeveld TP, et al. Voice outcome in T1a midcord glottic carcinoma: laser surgery vs radiotherapy. Arch Otolaryngol Head Neck Surg. 2008;134:965-72.
30. Núñez Batalla F, Caminero Cueva MJ, Señaris González B, et al. Voice quality after endoscopic laser surgery and radiotherapy for early glottic cancer: objective measurements emphasizing the Voice Handicap Index. Eur Arch Otorhinolaryngol. 2008;265:543-8.
31. Osborn HA, Hu A, Venkatesan V, et al. Comparison of endoscopic laser resection versus radiation therapy for the treatment of early glottic carcinoma. J Otolaryngol Head Neck Surg. 2011;40:200-4.
32. Dinapoli N, Parrilla C, Galli J, et al. Multidisciplinary approach in the treatment of T1 glottic cancer. The role of patient preference in a homogenous patient population. Strahlenther Onkol. 2010;186:607-13.
33. • Spielmann PM, Majumdar S, Morton RP. Quality of life and functional outcomes in the management of early glottis carcinoma: a systematic review of studies comparing radiotherapy and transoral laser microsurgery. Clin Otolaryngol. 2010;35:373-82. This is a comprehensive systematic review analyzing vocal outcomes.
34. Suárez C, Rodrigo JP, Silver CE, et al. Laser surgery for early to moderately advanced Glottic. Supraglottic and Hypopharyngeal Cancers. Head Neck. 2012;34:1028-35.
35. Rudert HH, Werner JA, Höft S. Transoral carbon dioxide laser resection of supraglottic carcinoma. Ann Otol Rhinol Laryngol. 1999;108:819-27.
36. Ambrosch P, Kron M, Steiner W. Carbon dioxide laser microsurgery for early supraglottic carcinoma. Ann Otol Rhinol Laryngol. 1998;107:680-8.
37. Motta G, Esposito E, Testa D, et al. CO2 laser treatment of supraglottic cancer. Head Neck. 2004;26:442-6.
38. 2 laser surgery for supraglottic cancer. Eur Arch Otorhinolaryngol. 2012;269:2081-6.
39. Cabanillas R, Rodrigo JP, Llorente JL, Suárez C. Oncologic outcomes of transoral laser surgery of supraglottic carcinoma compared with a transcervical approach. Head Neck. 2008;30:750-5.
40. Bussu F, Almadori G, De Corso E, et al. Endoscopic horizontal partial laryngectomy by CO(2) laser in the management of supraglottic squamous cell carcinoma. Head Neck. 2009;31:1196-206.
41. Roh JL, Kim DH, Park CI. Voice, swallowing and quality of life in patients after transoral laser surgery for supraglottic carcinoma. J Surg Oncol. 2008;98:184-9.
42. Cabanillas R, Rodrigo JP, Llorente JL, et al. Functional outcomes of transoral laser surgery of supraglottic carcinoma compared with a transcervical approach. Head Neck. 2004;26:653-9.
43. Peretti G, Piazza C, Cattaneo A, et al. Comparison of functional outcomes after endoscopic versus open-neck supraglottic laryngectomies. Ann Otol Rhinol Laryngol. 2006;115:827-32.
44. Rodrigo JP, Suárez C, Silver CE, et al. Transoral laser surgery for supraglottic cancer. Head Neck. 2008;30:658-66.
45. Vilaseca I, Blanch JL, Bernal-Sprekelsen M. Transoral laser surgery for hypopharyngeal carcinomas. Curr Opin Otolaryngol Head Neck Surg. 2012;20:97-102.
46. Lefebvre JL. What is the role of primary surgery in the treatment of laryngeal and hypopharyngeal cancer? Hayes Martin lecture. Arch Otolaryngol Head Neck Surg. 2000;126:285-8.
47. Rudert HH, Höft S. Transoral carbon-dioxide laser resection of hypopharyngeal carcinoma. Eur Arch Otorhinolaryngol. 2003;260:198-206.
48. Kutter J, Lang F, Monnier P, Pasche P. Transoral laser surgery for pharyngeal and pharyngolaryngeal carcinomas. Arch Otolaryngol Head Neck Surg. 2007;133:139-44.
49. Karatzanis AD, Psychogios G, Waldfahrer F, et al. T1 and T2 hypopharyngeal cancer treatment with laser microsurgery. J Surg Oncol. 2010;102:27-33.
50. Vilaseca I, Blanch JL, Bernal-Sprekelsen M, Moragas M. CO2 laser surgery: a larynx preservation alternative for selected hypopharyngeal carcinomas. Head Neck. 2004;26:953-9.
51. Martin A, Jäckel MC, Christiansen H, et al. Organ preserving transoral laser microsurgery for cancer of the hypopharynx. Laryngoscope. 2008;118:398-402.
52. Parsons JT, Mendenhall WM, Stringer SP, et al. Squamous cell carcinoma of the oropharynx: surgery, radiation therapy, or both. Cancer. 2002;94:2967-80.
53. Eckel HE, Volling P, Pototschnig C, et al. Transoral laser resection with staged discontinuous neck dissection for oral cavity and oropharynx squamous cell carcinoma. Laryngoscope. 1995;105:53-60.
54. Steiner W, Fierek O, Ambrosch P, et al. Transoral laser microsurgery for squamous cell carcinoma of the base of the tongue. Arch Otolaryngol Head Neck Surg. 2003;129:36-43.
55. Grant DG, Salassa Jr, Hinni ML, et al. Carcinoma of the tongue base treated by transoral laser microsurgery, part one: untreated tumors, a prospective analysis of oncologic and functional outcomes. Laryngoscope 2006;116:2150-2155.
56. Camp AA, Fundakowski C, Petruzzelli GJ, et al. Functional and oncologic results following transoral laser microsurgical excision of base of tongue carcinoma. Otolaryngol Head Neck Surg. 2009;141:66-9.
57. Henstrom DK, Moore EJ, Olsen KD, et al. Transoral resection for squamous cell carcinoma of the base of tongue. Arch Otolaryngol Head Neck Surg. 2009;135:1231-8.
58. Rich JT, Milov S, Lewis Jr JS, et al. Transoral laser microsurgery (TLM) +/- adjuvant therapy for advanced stage oropharyngeal cancer: outcomes and prognostic factors. Laryngoscope. 2009;119:1709-19.
59. • Haughey BH, Hinni ML, Salassa JR, et al. Transoral laser microsurgery as primary treatment for advanced-stage oropharyngeal cancer: a United States multicenter study. Head Neck. 2011;33:1683-94. This multicenter study demonstrated the feasibility of TLM as a valid alternative to chemoradiotherapy in advanced oropharyngeal carcinoma.
60. Forastiere AA, Goepfert H, Maor M, et al. Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. N Engl J Med. 2003;349:2091-8.
61. Urba S, Wolf G, Eisbruch A, et al. Single-cycle induction chemotherapy selects patients with advanced laryngeal cancer for combined chemoradiation: a new treatment paradigm. J Clin Oncol. 2006;24:593-8.
62. León X, López M, García J, Quer M. Results of an organ conservation protocol in patients with locally advanced laryngeal tumours. Acta Otorrinolaringol Esp. 2009;60:176-85.
63. Pointreau Y, Garaud P, Chapet S, et al. Randomized trial of induction chemotherapy with cisplatin and 5-fluorouracil with or without docetaxel for larynx preservation. J Natl Cancer Inst. 2009;101:498-506.
64. Mendenhall WM, Amdur RJ, Morris CG, Hinerman RW. T1-N0 squamous cell carcinoma of the glottic larynx treated with radiation therapy. J Clin Oncol. 2001;19:4029-36.
65. Chera BS, Amdur RJ, Morris CG, et al. T1N0 to T2N0 squamous cell carcinoma of the glottic larynx treated with definitive radiotherapy. Int J Radiat Oncol Biol Phys. 2010;78:461-6.
66. Warde P, O'Sullivan B, Bristow RG, et al. T1/T2 glottic cancer managed by external beam radiotherapy: the influence of pretreatment hemoglobin on local control. Int J Radiat Oncol Biol Phys. 1998;41:347-53.
67. Nakfoor BM, Spiro IJ, Wang CC, et al. Results of accelerated radiotherapy for supraglottic carcinoma: a Massachusetts General Hospital and Massachusetts Eye and Ear Infirmary experience. Head Neck. 1998;20:379-84.
68. Mahler V, Boysen M, Brøndbo K. Radiotherapy or CO(2) laser surgery as treatment of T(1a) glottic carcinoma? Eur Arch Otorhinolaryngol. 2010;267:743-50.